Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsThe history of neuromyelitis opticaAn update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis opticaThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesUpdate on biomarkers in neuromyelitis opticaInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersChallenges and opportunities in designing clinical trials for neuromyelitis opticaImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesBiomarkers of treatment response in multiple sclerosisEvaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeThe expanded spectrum of neuromyelitis optica: evidences for a new definition.Optic neuritis in neuromyelitis optica.Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case reportPatterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosisIntra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.Neuromyelitis optica - an update: 2007-2009Update on neuromyelitis optica: natural history and management.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases.Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus.Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postremaCerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceAutoimmune channelopathies: new antibody-mediated disorders of the central nervous systemPresence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis opticaPractical considerations on the use of rituximab in autoimmune neurological disordersThe cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
P2860
Q21093230-34C8277B-71EA-4CE8-8EC8-8E87C06C85ACQ21245248-DE5380D2-1A51-44EE-9F7C-589CFD695F46Q26748601-E851FFE4-2876-41E1-B7F4-EFF97EAEDBFFQ26767391-1EAF28E1-56AB-47C5-A000-D97DAA0A8F87Q26799789-28E76A02-114C-42EB-8C1A-7CA6B5A5340DQ26824579-176177B6-C071-4719-AC74-9AD519359E6DQ26999708-CC3719C4-8250-4CBF-AF5D-3B00CFF8271EQ27016045-19CE3CC9-EAB9-4B7D-B89C-38E044DB7ACBQ27021535-801E06BC-120F-49F3-B83C-5C92F1EFC44EQ28245749-4D7BBE4E-3F20-44CF-A881-4D598775597CQ28305094-40CA23B7-3E5F-46B2-B4E3-0999476B2269Q28728565-7EC74A12-E1CB-4447-BDC0-2D734CE880D4Q30371412-2C27E133-6786-4D0C-B75A-C05FCB7B1F98Q30573084-75D7181D-E028-47EE-9DB8-5B47F6850288Q30610471-B42676BB-473B-48AB-8B45-8C8CE539FA76Q30676331-9475DBC9-621E-4CC1-BBE4-99DC1108E808Q30785267-5DBFE44F-D831-4D0D-8B16-A5481A775B55Q33512099-A3B20AE5-B350-44E2-A085-3786701FBAF5Q33576962-3ABEAE79-BB3D-4E65-9CD6-14974928D683Q33611158-09724F24-D85C-4EEF-91F7-E8B94D2268DBQ33656297-E324C765-A591-4DD2-9236-9017EC53BE61Q33670918-A2F20A70-72BD-4371-816F-DC856D020974Q33702126-2A0B2E9B-5B14-498B-B9CC-477602DC3C12Q33770508-0C8D0EF6-E5D4-49DE-BE89-625699984280Q33808279-F157CE61-4BB6-4F29-9ABD-E5D20453E61DQ33882739-DFD919D0-42A3-48A0-BFFA-D65C1129F1A5Q33892764-9770CEA5-C749-4B3B-B027-7A3720905DDBQ33909097-B10D2128-62A0-4BDF-84E8-F0C666A4527EQ34004654-DE40B028-C3A9-4F65-AD57-4B7D657233B4Q34026880-B776A8CB-E696-44B0-ABED-B81E2037A7A1Q34061733-F97A8352-D3E4-4F99-9B7A-4994F58E3701Q34072723-312D8219-1CE0-469C-A4A8-3AE37F18BF1CQ34154277-ACBE90EA-D00C-4FD1-8F0D-BE5C2F617C73Q34167246-152C1E76-98EF-4B8F-9060-26F225406992Q34338762-FA1C0237-F82A-4A36-8F7C-EBC052FFC181Q34409447-9870DCD1-9A85-4BF8-B561-131FD1B6DA84Q34459965-C60165C0-68C5-4A52-A4CB-73F705581240Q34497097-99B4CA38-6E6A-4301-9D47-2D61625D4C29Q34621516-3F342192-98E1-4A54-A1D4-2D82FE3E73F3Q34793304-4E1CF45B-1588-44AF-9219-404FEA2EE489
P2860
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
@en
type
label
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
@en
prefLabel
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
@en
P2093
P2860
P356
P1433
P1476
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
@en
P2093
F Aboul-Enein
W Kristoferitsch
P2860
P304
P356
10.1093/BRAIN/AWN240
P407
P577
2008-10-22T00:00:00Z